Du är här


Navamedic ASA: Navamedic ASA Q2 2015 Report

After the end of the quarter Navamedic acquired the Swedish medtech company
Observe Medical International AB, which has developed the next generation
digital urine meter for use in intensive care, Sippi®. The innovative, patent
protected product has secured distribution in Germany and the Nordic markets
and holds global sales potential in a market worth approximately two Bn NOK,
Navamedic expects a strong future sales growth for Sippi®

Navamedic's revenues in the second quarter 2015 were in line with the same
quarter last year, while sales for the first half of the year saw a 19%
growth compared to previous year.

Profitability compared to previous year improved, in the second quarter as
well as year to date. Inventories were reduced, and cash flow from operations
improved considerably.

Contact Navamedic ASA:

CEO Tom Rönnlund
E-mail: tom.ronnlund@navamedic.com
Mobile +46 727 320 321

CFO Bjørn Lindholt
E-mail: bjorn.lindholt@navamedic.com
Mobile: +47 93 00 66 01

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Navamedic ASA Q2 2015 Report
Navamedic ASA Q2 2015 Presentation


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.